Initial Screen: Client molecule(s) encapsulation evaluation, CND™ “tunable” studies, Controlled release studies(in vitro)
Future Development: In vivo studies (e.g. PK), Pre-clinical Efficacy, Combination Therapy Studies, Process Scalability
Driving Innovation with Our Trusted Technology Partners
Accelerating the future with visionary partners and innovative solutions.